Brief: Diagnos announces DTC eligibility of its common shares in the U.S.
26/09/2017 14:03
Sept 26 (Reuters) - Diagnos Inc ADK.V
* Diagnos announces DTC eligibility of its common shares in
the US
Source text for Eikon: ID:nCCNjHBBYa
Further company coverage: ADK.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Diagnos
See all newsBrief: Diagnos Submits Modified And Updated Health Canada Licence Application For Cara System Platform
Brief: Diagnos To Submit Future CARA Version To FDA Before End Of Q3
Brief: Diagnos Welcomes Dr. Pierre-Luc Charlebois To Its Advisory Board
Brief: Validated For Global Scale Diagnos Passes Annual MDSAP Audit, Solidifying The Pathway To Approvals With Health Canada & FDA
Brief: Diagnos Provides Update On Its Health Canada Medical Device Licence Application